216 related articles for article (PubMed ID: 28319501)
1. 18F-Fluorocholine PET/CT, Brain MRI, and 5-Aminolevulinic Acid for the Assessment of Tumor Resection in High-Grade Glioma.
García Vicente AM; Jiménez Aragón F; Villena Martín M; Jiménez Londoño GA; Borrás Moreno JM
Clin Nucl Med; 2017 Jun; 42(6):e300-e303. PubMed ID: 28319501
[TBL] [Abstract][Full Text] [Related]
2. Ischemic Complications After High-Grade Glioma Resection Could Interfere With Residual Tumor Detection With 18F-Fluorocholine PET/CT.
García Vicente AM; Rodriguez Muñoz MJ; Pena Pardo FJ; Martinez Madrigal MM; Soriano Castrejón A
Clin Nucl Med; 2019 Feb; 44(2):e76-e84. PubMed ID: 30516681
[TBL] [Abstract][Full Text] [Related]
3. Comparison of dual-time point 18F-FDG PET/CT tumor-to-background ratio, intraoperative 5-aminolevulinic acid fluorescence scale, and Ki-67 index in high-grade glioma.
Kim YI; Cho KG; Jang SJ
Medicine (Baltimore); 2019 Feb; 98(8):e14397. PubMed ID: 30813140
[TBL] [Abstract][Full Text] [Related]
4. FuMeGA Criteria for Visual Assessment of Postoperative 18F-Fluorocholine PET in Patients With Glioma.
García Vicente AM; Pena Pardo FJ; Lozano Setien E; Sandoval Valencia H; Villena Martín M
Clin Nucl Med; 2020 Jun; 45(6):448-450. PubMed ID: 32349093
[TBL] [Abstract][Full Text] [Related]
5. Comparison of effects of 18F-FDG PET-CT and MRI in identifying and grading gliomas.
Song PJ; Lu QY; Li MY; Li X; Shen F
J Biol Regul Homeost Agents; 2016; 30(3):833-838. PubMed ID: 27655507
[TBL] [Abstract][Full Text] [Related]
6. Low-Grade Versus High-Grade Glioma… That Is the Question. 18F-Fluorocholine PET in the Detection of Anaplastic Focus.
García Vicente AM; Cordero García JM; López Menéndez C; Borrás Moreno JM; Soriano Castrejón A
Clin Nucl Med; 2020 May; 45(5):394-397. PubMed ID: 32209884
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of O-(2-[18F]-Fluoroethyl)-L-Tyrosine-Positron Emission Tomography Imaging for Histopathologic Characteristics and Progression-Free Survival in Patients with Low-Grade Glioma.
Bette S; Gempt J; Delbridge C; Kirschke JS; Schlegel J; Foerster S; Huber T; Pyka T; Zimmer C; Meyer B; Ringel F
World Neurosurg; 2016 May; 89():230-9. PubMed ID: 26855307
[TBL] [Abstract][Full Text] [Related]
8. Promising role of [18F] fluorocholine PET/CT vs [18F] fluorodeoxyglucose PET/CT in primary brain tumors-early experience.
Lam WW; Ng DC; Wong WY; Ong SC; Yu SW; See SJ
Clin Neurol Neurosurg; 2011 Feb; 113(2):156-61. PubMed ID: 21036467
[TBL] [Abstract][Full Text] [Related]
9. Diverse Behavior in 18F-Fluorocholine PET/CT of Brain Tumors in Patients With Neurofibromatosis Type 1.
Pena Pardo FJ; Moreno JMB; Jiménez Aragón F; González García J; García Vicente AM
Clin Nucl Med; 2019 Aug; 44(8):e472-e476. PubMed ID: 31274626
[TBL] [Abstract][Full Text] [Related]
10. Impact of [18F]-fluoro-ethyl-tyrosine PET imaging on target definition for radiation therapy of high-grade glioma.
Munck Af Rosenschold P; Costa J; Engelholm SA; Lundemann MJ; Law I; Ohlhues L; Engelholm S
Neuro Oncol; 2015 May; 17(5):757-63. PubMed ID: 25537018
[TBL] [Abstract][Full Text] [Related]
11. Impact of the combination of 5-aminolevulinic acid-induced fluorescence with intraoperative magnetic resonance imaging-guided surgery for glioma.
Tsugu A; Ishizaka H; Mizokami Y; Osada T; Baba T; Yoshiyama M; Nishiyama J; Matsumae M
World Neurosurg; 2011; 76(1-2):120-7. PubMed ID: 21839963
[TBL] [Abstract][Full Text] [Related]
12. Association of F18-fluoro-ethyl-tyrosin uptake and 5-aminolevulinic acid-induced fluorescence in gliomas.
Stockhammer F; Misch M; Horn P; Koch A; Fonyuy N; Plotkin M
Acta Neurochir (Wien); 2009 Nov; 151(11):1377-83. PubMed ID: 19639250
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Potential of Postoperative 18F-Fluorocholine PET/CT in Patients With High-Grade Glioma. Clinical Validation of FuMeGA Postoperative PET Criteria.
García Vicente AM; Pena Pardo FJ; Amo-Salas M; Villena Martín M; López Menéndez C; Soriano Castrejón ÁM; Pérez-Beteta J
Clin Nucl Med; 2022 Jun; 47(6):480-487. PubMed ID: 35426853
[TBL] [Abstract][Full Text] [Related]
14. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M
Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706
[TBL] [Abstract][Full Text] [Related]
15. ¹⁸F-Fluorocholine PET/CT as a complementary tool in the follow-up of low-grade glioma: diagnostic accuracy and clinical utility.
Gómez-Río M; Testart Dardel N; Santiago Chinchilla A; Rodríguez-Fernández A; Olivares Granados G; Luque Caro R; Zurita Herrera M; Chamorro Santos CE; Lardelli-Claret P; Llamas-Elvira JM
Eur J Nucl Med Mol Imaging; 2015 May; 42(6):886-95. PubMed ID: 25673054
[TBL] [Abstract][Full Text] [Related]
16. Metabolic approach for tumor delineation in glioma surgery: 3D MR spectroscopy image-guided resection.
Zhang J; Zhuang DX; Yao CJ; Lin CP; Wang TL; Qin ZY; Wu JS
J Neurosurg; 2016 Jun; 124(6):1585-93. PubMed ID: 26636387
[TBL] [Abstract][Full Text] [Related]
17. Multicentric glioma studied with positron emission tomography: a case report.
Sato K; Kameyama M; Ishiwata K; Kayama T; Yoshimoto T; Ito M
Surg Neurol; 1994 Jul; 42(1):14-8. PubMed ID: 7940089
[TBL] [Abstract][Full Text] [Related]
18. The usefulness of 18F-fluorocholine PET/CT in the detection of recurrence of central nervous system primary neoplasms.
Montes A; Fernández A; Camacho V; de Quintana C; Gallego O; Craven-Bartle J; López D; Molet J; Gómez-Ansón B; Carrió I
Rev Esp Med Nucl Imagen Mol; 2017; 36(4):227-232. PubMed ID: 28219644
[TBL] [Abstract][Full Text] [Related]
19. Is It Possible to Establish the Extent of Resection of Glioblastoma With 18F-Fluorocholine PET/CT?
García Vicente AM; Perez-Beteta J; Calvo García M; Villena Martín M; Soriano Castrejón A
Clin Nucl Med; 2018 Aug; 43(8):e269-e273. PubMed ID: 29894332
[TBL] [Abstract][Full Text] [Related]
20. Illustration of the Added Value of 18F-DOPA PET to Multimodal MRI to Distinguish Low- and High-Grade Gliomas.
Louarn N; Kauv P; Capelle L; Mokhtari K; Itti E
Clin Nucl Med; 2021 Jul; 46(7):e353-e354. PubMed ID: 33577196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
